Edwards Lifesciences (Switzerland)

Edwards Lifesciences (Switzerland)

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Edwards Lifesciences (Switzerland), Switzerland, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

55%


Total
Publications

294


Total Open
Publications

162


Total
Citations

11K


Open Access
Percentage

55%


Total
Publications

294


Total Open
Publications

162


Total
Citations

11K

Wikipedia

Website

download

Breakdown

26% 23% 5% 46%

Publisher Open

26%

Both

23%

Other Platform Open

5%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

51

Hybrid 30%

42

No Guarantees 34%

47

Other Platform Open

Domain 71%

60

Institution 44%

37

Other Internet 13%

11

Preprint 2%

2

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
60
DANS - Data Archiving and Networked Services
Institution
14
DOI
Other Internet
9
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
7
University of Bari Aldo Moro - CINECA IRIS Institutional Research Information System
Institution
6
University of Florence - Florence Research
Institution
5
universiteitleiden.nl OAI-PMH Repository
Institution
5
Konstfack University of Arts, Crafts, and Design - Publications
Institution
5
Europe PMC
Domain
5
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
3
1 / 5

Data updated 18 August 2025

Share

Share

Share